Notably, in the Wnt1 tumor syngeneic mouse model, E-7386 alone exhibited significant antitumor activity, whereas the combination of E-7386 and anti-PD-1 mAb enhanced antitumor effects beyond those achieved by either treatment alone [72]. Here, WNT1 is linked to neoplasm.